Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO
Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates the efficiency of ICS(budesonide) combined with LABA (formoterol) and
LAMA(tiotropium) in the treatment of acute exacerbation of asthma-chronic obstructive
pulmonary overlap. Half of participants will receive budesonide,formoterol and tiotropium in
combination, while the other half will receive budesonide and formoterol only.